Previous 10 | Next 10 |
ALPHARETTA, Ga. , Jan. 8, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the 38 th Annual J.P. Morgan Healthcare Conference on Wednesday Jan. 15 at approximately 2 p.m. PT at the Westin St. Franci...
ALPHARETTA, Ga. , Dec. 30, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the appointment of Michael C. Greiner as senior vice president and chief financial officer, effective Jan. 1, 2020 . Greiner brings to Avanos more than 20 years of experience...
ALPHARETTA, Ga. , Nov. 13, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the Stifel 2019 Healthcare Conference in New York City on Wednesday, Nov. 20 at approximately 8 a.m., ET . A webc...
Global Blood Therapeutics (NASDAQ: GBT ) initiated with Hold rating and $50 (flat) price target at Canaccord Genuity. More news on: Global Blood Therapeutics, Inc., Momenta Pharmaceuticals, Inc., Pacira BioSciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
ALPHARETTA, Ga. , Nov. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Crawford , vice president of investor relations, will present at the Stephens Nashville Investment Conference at the Omni Nashville hotel in Nashville, TN on Wednesday, Nov. 13 ...
Image source: The Motley Fool. Avanos Medical, Inc. (NYSE: AVNS) Q3 2019 Earnings Call Nov 5, 2019 , 9:00 a.m. ET Operator Continue reading
Avanos Medical, Inc. (AVNS) Q3 2019 Results Conference Call November 05, 2019 10:00 AM ET Company Participants Dave Crawford - Vice President of Investor Relations Joe Woody - Chief Executive Officer Conference Call Participants Chris Cooley - Stephens Matthew Mishan - KeyB...
The following slide deck was published by Avanos Medical, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Avanos Medical ( AVNS -20.3% ) is down on almost a 4x surge in volume on the heels of its Q3 results that were shy of expectations. Highlights: More news on: Avanos Medical, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Gainers : NextCure (NASDAQ: NXTC ) +183% . Fulgent Genetics (NASDAQ: FLGT ) +35% . NIO (NYSE: NIO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . EverQuote (NASDAQ: EVER ) +27% . Forterra (NASDAQ: FRTA ) +25% . Gaia (NASDAQ: GAIA ) +23% . Agile Therapeutics (NASDAQ: AGRX ) +23%...
News, Short Squeeze, Breakout and More Instantly...
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results PR Newswire ALPHARETTA, Ga. , July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and busine...
2024-07-19 23:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors PR Newswire ALPHARETTA, Ga. , July 1, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Ava...